Another State Calls it Quits with Pharmacy Benefit Managers
Michigan Medicaid has a message for the state’s pharmacy benefit managers: This isn’t working.
Hepatitis C Rates Spike Among Pregnant Women
New data show a startling trend: Rates of hepatitis C among pregnant women have significantly increased.
Making Step Therapy Safe for Patients
A new bill introduced in the U.S. Senate would curb the health plan practice of requiring patients to try and fail an insurer-preferred drug before getting the one their doctor prescribed.
ICER Fumbles Rheumatoid Arthritis Report
The controversial Institute for Clinical and Economic Review has done something unprecedented: admitted it’s wrong.
“Why Care?” about Mental Illness
Patients and advocates for mental health will repeatedly answer the question “Why Care?” this week.
Uncertainty Plagues ICER Report on Type 2 Diabetes
Just one thing stands between some Type 2 diabetes patients and disease management: a dislike of needles.
Federal Trade Commission Stands with Patients on “Bad Drug” Ads
For years, patients have been misled by “bad drug” ads that frighten them into abandoning their prescription medications. Now the Federal Trade Commission is speaking out.
Prior Authorization Delays Treatment & Increases Rx Steroid Use
New data prove a point that clinicians and advocates have been making for years: Prior authorization hurts patients.
Medicare Move Could Improve Treatment Access for Heart Patients
A recent Trump administration decision nudges health plans to do right by patients who struggle with high LDL, or “bad,” cholesterol.
Medicare Part D: Not as Simple as ‘ABC’
Maybe lawmakers intended Medicare to be as simple as A, B, C.
